Industry

DUBLIN–(BUSINESS WIRE)–The “Global Mass Spectrometer Market (2022-2027) by Technology, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Mass Spectrometer Market is estimated to be USD 4.44 Bn in 2022 and is projected to reach USD 6.29 Bn by 2027, growing … [Read more…]

Common Stock Will Begin Trading on a Split-Adjusted Basis on July 15, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Self-injections Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Self-injections Market is projected to reach USD 86,009.00 million by 2027 from USD 41,757.64 million in 2021, at a CAGR 12.79% during the forecast period. Key Findings: The Americas Self-injections Market size was estimated at … [Read more…]

HOUSTON–(BUSINESS WIRE)–#chronicdisease–As a nation, we continue to ignore the significant and lasting economic, social, and health impacts of nutrition insecurity at our own peril. Suboptimal diets are a leading risk factor for chronic diseases. With 6 in 10 adults in the U.S. living with a chronic condition, nearly 20% of children under 19 living with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Spray Drying Market – Growth, Trends, Covid-19 Impact, And Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Pharmaceutical Spray Drying market is projected to grow with a CAGR of 4.67% during the forecast period (2022 – 2027). Companies Mentioned GEA Group SPX Flow Hovione Catalent, Inc Fuji Chemical … [Read more…]

SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of a new paper in the journal Scientific Reports, entitled “Biometric and refractive changes following the monocular application of peripheral myopic defocus using a novel augmented-reality … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–$ELMT–Third paragraph, second sentence of the release dated July 13, 2022, should read: Rejuvenate™ Immune Health is available in 15-serve and 45-serve sizes and in an orange splash flavour. The updated release reads: ELEMENT NUTRITIONAL SCIENCES ANNOUNCES REJUVENATE™ IMMUNE HEALTH NOW AVAILABLE THROUGH AMAZON.COM Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Thrombosis Drug Market Research Report by Drug Class (Factor Xa Inhibitor, Heparin, and P2Y12 Platelet Inhibitor), Disease Type, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Thrombosis Drug Market size was … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Congenital Diarrheal Disorders – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Congenital Diarrheal Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United … [Read more…]

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the Centers for Medicare & Medicaid Services (CMS) ICD-10 Coordination and Maintenance Committee has issued a new ICD-10-PCS code for TherOx® SuperSaturated Oxygen (SSO2) Therapy. The new code (5A0222C), for cardiac intra-arterial use, is effective … [Read more…]